Sigurdís Haraldsdóttir

Author

Stanford University ORCID

Also Known As

Haraldsdottir, Sigurdis, S. Haraldsdottir, S. Haraldsdóttir, Sigurdis Haraldsdottir, Sigurdís Haraldsdóttir

102

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Stanford University The Ohio State University University of Washington The Ohio State University Wexner Medical Center University of Iceland

About

Sigurdís Haraldsdóttir is an author at Stanford University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.3K
2	Health Sciences	3	3	95
3	Public Health	1	1	333
4	Biochemistry	1	1	40
5	Epidemiology	1	1	333

Sigurdís Haraldsdóttir

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Colon and Endometrial Cancers With Mismatch Repair Deficiency Can Arise From Somatic, Rather Than Germline, Mutations Sigurdís Haraldsdóttir, Heather Hampel, Jerneja Tomšič, Gastroenterology Genome InstabilitySomatic VariantRather Than GermlineGeneticsGynecology	2014	370
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 Samir Gupta, Dawn Provenzale, Xavier Llor, Journal of the National Comprehensive Cancer Network Genetic TestingNccn Guidelines InsightsGenetic EpidemiologyPathologyGastroenterology	2019	333
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2 Sigurdís Haraldsdóttir, Wendy L. Frankel, Sylvia Einarsdottir, Nature Communications GeneticsGenetic EpidemiologyMolecular BiologyPathologyMolecular Genetics	2017	120
Prostate cancer incidence in males with Lynch syndrome Sigurdís Haraldsdóttir, Heather Hampel, Lai Wei, Genetics in Medicine UrologyProstate Cancer IncidenceCancer EpidemiologyGenitourinary CancerMedicine	2014	104
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome Rachel Pearlman, Sigurdís Haraldsdóttir, Albert de la Chapelle, Journal of Medical Genetics	2019	93
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study Elizabeth Bancroft, Elizabeth Page, Mark N. Brook, The Lancet Oncology	2021	89
Anti-Proliferative Effects of Lichen-Derived Lipoxygenase Inhibitors on Twelve Human Cancer Cell Lines of Different Tissue Origin<i>in vitro</i> Sigurdís Haraldsdóttir, Erna Guðlaugsdóttir, Kristı́n Ingólfsdóttir, Planta Medica	2004	65
Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer İbrahim Halil Şahin, Subir Goyal, Yoanna S Pumpalova, The Oncologist	2021	46
Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy Satya Das, Kristen K. Ciombor, Sigurdís Haraldsdóttir, The Oncologist Irae OnsetCancer ManagementImmunologyGastroenterologyImmunoediting	2020	42
Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis Sigurdís Haraldsdóttir, Rachel Roth, Rachel Pearlman, Familial Cancer Tumor BiologySurgical OncologyMedicinePrimary Colorectal CancerColorectal Cancer	2015	41

Page 1